论文部分内容阅读
目的探讨2型糖尿病经诺和锐30治疗的临床效果。方法选择2009年6月至2011年6月收治的老年糖尿病患者共80例患者的临床资料进行分析。结果本组80例患者的胰岛素用量逐渐减少,血糖控制良好而在治疗后3～6周后停用胰岛素;治疗3个月后,空腹血糖、餐后2 h血糖、糖化血红蛋白与治疗前比较均有统计学差异(P<0.05)。结论诺和锐30治疗2型糖尿病临床疗效好,可明显改善患者的生存质量,值得临床应用。
Objective To investigate the clinical effect of Novo-Rui-30 treatment of type 2 diabetes mellitus. Methods The clinical data of 80 patients with senile diabetes who were admitted from June 2009 to June 2011 were analyzed. Results In the 80 patients, insulin dosage gradually decreased, blood glucose was well controlled and insulin was discontinued 3 to 6 weeks after treatment. After 3 months of treatment, fasting blood glucose, postprandial 2h blood glucose and glycosylated hemoglobin were both lower than those before treatment There was a significant difference (P <0.05). Conclusion Novo Rui 30 treatment of type 2 diabetes clinical efficacy is good, can significantly improve the quality of life of patients, it is worth clinical application.